89 patients with acute leukemia were studied for the frequencies of HLA-A and HLA-B antigens. In this series, the frequency of the antigen A2 was increased in children with acute lymphoblastic leukemia and that of B12 in adults with acute lymphoblastic leukemia. No precise antigen was associated with acute myeloblastic leukemia at presentation, but survival analysis showed that patients positive for the antigen(s) A2 and/or B12 did significantly better in terms of mean survival. Mechanisms by which HLA antigens may interact with the established disease and with the treatment are discussed.
This content is only available via PDF.
© 1981 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.